Cullinan Associates’s Pitney Bowes PBI Stock Holding History

Cullinan Associates’s Portfolio PBI Stock Details PBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,400	Closed	-$69K	–	242
2021 Q4	$69K	Hold	10,400	–	–	﹤0.01%	235
2021 Q3	$75K	Hold	10,400	–	–	﹤0.01%	233
2021 Q2	$91K	Hold	10,400	–	–	0.01%	220
2021 Q1	$86K	Hold	10,400	–	–	﹤0.01%	211
2020 Q4	$64K	Buy	+10,400	New	+$62.5K	﹤0.01%	190

Other funds holding PBI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cullinan Associates's PBI Position: Q1 2022 in Review

Cullinan Associates sold out of Pitney Bowes (PBI) in Q1 2022, closing a stake of 10,400 shares — an estimated $69K sold.

Cullinan Associates first reported a position in PBI in Q4 2020 and held it in 5 quarters. The position peaked at $91K in Q2 2021. 258 funds tracked by Wall St. Rank hold PBI as of Q1 2022.

Cullinan Associates reported no remaining Pitney Bowes position as of Q1 2022 after selling out during the quarter.
Cullinan Associates sold 10,400 Pitney Bowes shares in Q1 2022, an estimated $69K.
Cullinan Associates first reported a position in Pitney Bowes in Q4 2020 and held it in 5 quarters.
Cullinan Associates's Pitney Bowes position peaked at $91K in Q2 2021.
258 funds tracked by Wall St. Rank held Pitney Bowes as of Q1 2022.

Based on Cullinan Associates's 13F filing for Q1 2022, filed 21 Apr 2022.